Periodontitis and Diabetes Differentially Affect Inflammation in Obesity
- 9 October 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Dental Research
- Vol. 103 (12) , 1313-1322
Abstract
Periodontitis (PD) potentiates systemic inflammatory diseases and fuels a feed-forward loop of pathogenic inflammation in obesity and type 2 diabetes (T2D). Published work in this area often conflates obesity with obesity-associated T2D; thus, it remains unclear whether PD similarly affects the inflammatory profiles of these 2 distinct systemic diseases. We collected peripheral blood mononuclear cells (PBMCs) from cross-sectionally recruited subjects to estimate the ability of PD to affect cytokine production in human obesity and/or T2D. We analyzed 2 major sources of systemic inflammation: T cells and myeloid cells. Bioplex quantitated cytokines secreted by PBMCs stimulated with T cell– or myeloid-targeting activators, and we combinatorially analyzed outcomes using partial least squares discriminant analysis. Our data show that PD significantly shifts peripheral T cell– and myeloid-generated inflammation in obesity. PD also changed myeloid- but not T cell–generated inflammation in T2D. T2D changed inflammation in samples from subjects with PD, and PD changed inflammation in samples from subjects with T2D, consistent with the bidirectional relationship of inflammation between these 2 conditions. PBMCs from T2D subjects with stage IV PD produced lower amounts of T cell and myeloid cytokines compared with PBMCs from T2D subjects with stage II to III PD. We conclude that PD and T2D affect systemic inflammation through overlapping but nonidentical mechanisms in obesity, indicating that characterizing both oral and metabolic status (beyond obesity) is critical for identifying mechanisms linking PD to systemic diseases such as obesity and T2D. The finding that stage IV PD cells generate fewer cytokines in T2D provides an explanation for the paradoxical findings that the immune system can appear activated or suppressed in PD, given that many studies do not report PD stage. Finally, our data indicate that a focus on multiple cellular sources of cytokines will be imperative to clinically address the systemic effects of PD in people with obesity.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (R01DE025383)
- National Institute of Dental and Craniofacial Research (U01DE025383)
- University of Kentucky Research
- Division of Diabetes, Endocrinology, and Metabolic Diseases (R01DK108056)
- Barnstable Brown Diabetes Center
- College of Dentistry, University of Kentucky
This publication has 28 references indexed in Scilit:
- T cells dominate peripheral inflammation in a cross‐sectional analysis of obesity‐associated diabetesObesity, 2022
- Origin of Th17 Cells in Type 2 Diabetes-Potentiated Periodontal Disease2019
- Levels of advanced glycation end products in gingival crevicular fluid of chronic periodontitis patients with and without type‐2 diabetes mellitusJournal of Periodontology, 2019
- Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 DiabetesCell Metabolism, 2019
- Periodontal Disease, Systemic Inflammation and the Risk of Cardiovascular DiseaseHeart, Lung and Circulation, 2018
- Staging and grading of periodontitis: Framework and proposal of a new classification and case definitionJournal of Periodontology, 2018
- Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and ConditionsJournal of Periodontology, 2018
- Th17 cytokines differentiate obesity from obesity‐associated type 2 diabetes and promote TNFα productionObesity, 2015
- Comparison of the variable importance in projection (VIP) and of the selectivity ratio (SR) methods for variable selection and interpretationJournal of Chemometrics, 2015
- Partial least squares analysis with cross‐validation for the two‐class problem: A Monte Carlo studyJournal of Chemometrics, 1987